Back to search

Article

The caninized anti-canine PD-1 monoclonal antibody in canine oral malignant melanoma: Efficacy and exploratory biomarker analysis

2025-08-28

Abstract excerpt

<h4>ABSTRACT</h4> <h4>Background</h4> Canine oral malignant melanoma (OMM) is a highly aggressive tumor with few treatment options. Because of its biological similarity to human mucosal melanoma, canine OMM represents a valuable spontaneous model for translational immunotherapy studies. Anti-PD-1 antibody therapy has shown promise in canine OMM; however, predictive biomarkers for treatment response and survival...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
cf6e282e-a1f2-531b-adab-6e1ac44140cc
DOI
10.1101/2025.08.26.671889
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
The caninized anti-canine PD-1 monoclonal antibody in canine oral malignant melanoma: Efficacy and exploratory biomarker analysisDOI 10.1101/2025.08.26.671889
Select a neighboring publication to make it the new centre.